I Sens Inc
KOSDAQ:099190
Operating Margin
I Sens Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
KR |
I
|
I Sens Inc
KOSDAQ:099190
|
458.8B KRW |
1%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
230.9B USD |
17%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
194.9B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
155.7B USD |
19%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
145.1B USD |
22%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
108.3B USD |
19%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
54.7B EUR |
14%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49.8B USD |
13%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.8B USD |
28%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
40.3B USD |
29%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
274.8B CNY |
34%
|
I Sens Inc
Glance View
i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on I Sens Inc's most recent financial statements, the company has Operating Margin of 0.9%.